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 21 
Abstract 22 
We assessed the additional diagnostic yield for M. tuberculosis blood stream infection (MTB 23 
BSI) from doing more than one TB blood culture in HIV-infected inpatients. In a retrospective 24 
analysis of two cohorts based in Cape Town, South Africa, 72/99 (73%) patients with MTB BSI 25 
were identified by the first of two blood cultures during the same admission, with 27/99 (27%, 26 
95%CI 18 to 36%) negative on first culture but positive on second. In a prospective evaluation of 27 
up to 6 blood cultures over 24 hours, 9 out of 14 patients with MTB BSI (65%) grew M. 28 
tuberculosis on their first blood culture; 3 more patients (21%) were identified by a second 29 
independent blood culture at the same time point, and the remaining 2 diagnosed only on 4th 30 
and 6th blood cultures respectively. Additional blood cultures increase the yield for MTB BSI, 31 
similar to what is reported for non-mycobacterial BSI. 32 
 33 
Introduction 34 
Mycobacterium tuberculosis blood stream infection (MTB BSI) is a frequent and life-threatening 35 
presentation of tuberculosis in high HIV burden settings. Published cohorts of HIV-1-infected 36 
inpatients with suspected tuberculosis show a point prevalence ranging from 9%(1) to 38%(2) 37 
on a single blood culture. MTB BSI has been associated with severe sepsis,(2-5) and high risk of 38 
death,(5-8) in people living with HIV. 39 
Several methods for recovery of mycobacteria from blood exist, including a manual solid-media 40 
based lysis-centrifugation system (Wampole™ Isostat®/Isolator ™ Microbial System, 41 
BioMerieux, Durham, NC, USA), and automated liquid-media systems (MB BacT/Alert®, 42 
Inverness, Waltham, MA, USA; Bactec Myco/F Lytic®, BD Microbiology Systems, Sparks, MD). 43 
Broth-based systems are probably more sensitive than agar.(8, 9) Beyond this, there is limited 44 
data on how to optimise blood culture for diagnosis of MTB BSI. 45 
By contrast, evidenced-based recommendations on the number, timing, and volume of blood 46 
cultures are available for non-mycobacterial BSI, where a single 10-mL blood culture will detect 47 
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73% and four samples will detect 90–95% of patients with documented bacteraemia.(10, 11) 48 
Almost all published studies of MTB BSI have performed a single 3-5ml liquid mycobacterial 49 
culture, and the proportion of MTB BSI missed by this strategy is unknown. We estimated the 50 
diagnostic yield of additional (>1) blood cultures for MTB in two ways: 51 
1. retrospectively, in two large cohort studies of HIV-associated TB conducted in hospital 52 
settings; and 53 
2. in a prospective evaluation of serial blood cultures in HIV-infected patients at high risk 54 
of MTB BSI in a hospital setting. 55 
Materials and methods 56 
Ethical approval was granted by the Human Research Ethics Committee University of Cape 57 
Town (Ref 001/2012, Ref 057/2013, and 057/2013 amendment 24/04/2016). Both the 58 
cohort studies and the prospective evaluation were carried out in the Western Cape, South 59 
Africa, a setting in which HIV and TB are the most common causes of death among adults, 60 
despite a well-functioning anti-retroviral programme.(12) The GF Jooste Hospital TB (JHTB) 61 
study recruited unselected HIV-infected patients newly admitted to acute medical services  62 
at GF Jooste Hospital without a known TB diagnosis and not on anti-TB therapy. These 63 
patients underwent extensive microbiological screening for TB including a single 5ml BD 64 
Bactec Myco/F Lytic blood culture (BD, Sparks, MD) on the day of admission.(13) The 65 
Khayelitsha Hospital (KHTB) study recruited HIV-infected patients admitted with symptoms 66 
suggestive of active tuberculosis and a CD4 count less than 350 cells/mm3, and also 67 
performed a routine 3-5ml Bactec Myco/F Lytic blood culture prior to start of anti-TB 68 
therapy.(14) Both these hospitals had access to mycobacterial blood culture investigations 69 
through the National Health Laboratory Service (NHLS). A subset of patients in both cohorts 70 
had an additional MTB blood culture which was requested by their admitting medical team 71 
if clinically indicated (local guidelines recommend TB blood culture if CD4 count is less than 72 
100 cells/mm3, in a patient with TB symptoms where there is difficulty obtaining sputum 73 
samples for TB testing or the sputum Xpert MTB/RIF assay is negative, and cultures are 74 
generally sent before start of anti-TB therapy). By interrogating the NHLS electronic 75 
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database we identified the subset of patients in both cohorts who had a second BD Bactec 76 
Myco/F Lytic blood culture carried out as part of routine care during the same admission as 77 
their study recruitment. 78 
To enrich recruitment to the prospective study of serial blood cultures, we used data from 79 
n=350 KHTB patients to develop a model predicting MTB BSI in patients using only clinical 80 
variables available on day of admission to Khayelitsha Hospital.(15) This model used an 81 
ensemble machine learning approach combining logistic regression, random forest, and 82 
support vector machine methods, and gave Receiver Operator Characteristic (ROC) curve 83 
area under curve 0.86 in a test data set comprising 66 KHTB patients not used in model 84 
training. This ensemble model was packaged in a web-based application available at the 85 
patient bedside via a smart phone.(16)   86 
Between 21 June 2016 and 19 October 2016, on weekdays Monday-Thursday, all HIV-87 
infected patients newly admitted to Khayelitsha Hospital with CD4 count < 350 cells/uL and 88 
suspected TB but not yet started on anti-TB therapy, were screened using the MTB BSI 89 
prediction app. Patients with predicted probability greater than 0.56 who gave informed 90 
consent, underwent 3 venesections over a 24-hour period: immediately before (0 hours), 4-91 
8 hours after, and 22-24 hours after first dose of anti-TB therapy. At each of these 92 
venesections, 5ml of peripheral blood was directly inoculated into a Myco/F Lytic BACTEC  93 
(BD, Sparks, MD) bottle, while 5ml was collected in a sodium heparin tube, immediately 94 
centrifuged for 25 minutes at 3000 G, and the resulting cell pellet (red cells and buffy coat) 95 
inoculated into a Myco/F Lytic bottle. Samples were transported to an NHLS TB laboratory 96 
in Cape Town for incubation the same day. Isolate identity was confirmed in all cases by 97 
secondary Löwenstein–Jensen slope culture, auramine acid-fast microscopy, and PCR / line 98 
probe assay.  99 
Results 100 
Using data from two independent cohort studies - the GF Jooste Hospital TB (JHTB) study, and 101 
the Khayelitsha Hospital TB (KHTB) study – we identified HIV-infected inpatients who had 102 
multiple mycobacterial blood culture performed during a single admission to hospital with 103 
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suspected TB. More than one blood culture was recorded for 59/410 JHTB patients and 104 
169/680 KHTB patients, giving n=228 total for analysis. Of these patients, 99/228 (43%) had at 105 
least one blood culture positive for M. tuberculosis (20/59 in JHTB, and 79/169 in KHTB). 106 
Overall, 72/99 (0.73; 95%CI = 0.64 to 0.82) of MTB BSIs were identified on the first culture, 107 
while 27/99 (0.27; 95%CI = 0.18 to 0.36) had negative first culture but grew M. tuberculosis on 108 
the second (table 1).   109 
To further investigate the yield of additional mycobacterial blood cultures, we carried out a 110 
prospective evaluation of multiple blood cultures in sixteen HIV-infected inpatients at 111 
Khayelitsha Hospital. Based on baseline clinical variables and a machine learning algorithm, 112 
these patients were selected to have a high predicted probability of MTB BSI (see methods 113 
section).  A set of 2x 5ml blood cultures were performed at time 0 hours, 4-8 hours and 22-24 114 
hours after first dose of anti-TB medication, with a total of 6 cultures over a 24-hour period. 115 
Because of the potential for antimicrobial carry-over in blood, the second sample from each 116 
pair had plasma removed before inoculation by centrifuge pelleted cells. 117 
In total, 89 blood culture results were available in the 16 patients, with 7 results missing (figure 118 
1). Of these 32/89 (36%) were positive for M. tuberculosis. Pelleted samples were more likely to 119 
recover M. tuberculosis (19/44; 43%) than directly inoculated samples (13/45; 29%), but the 120 
difference may have been due to chance (p = 0.189 by Fisher’s exact test). 121 
Two independent blood culture samples were obtained at each time point. At least one blood 122 
culture was positive in 14/16 patients (87.5%). All isolates were identified as M. tuberculosis. 123 
Nine (9/14, 64%) of these patients were culture positive on the first sample from the pair of 124 
samples taken at 0-hours. A further 3/14 (21%) were culture negative on the first sample but 125 
grew M. tuberculosis on the second sample taken at 0-hour timepoint. This meant that 12/14 126 
(86%) of MTB BSI patients were identified by performing 2 independent cultures at the same 127 
time-point before antibiotic therapy. The remaining two patients were identified on the 4th and 128 
6th blood culture respectively (both pelleted before inoculation) (Figure 2). 129 
 130 
Discussion 131 
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Using two independent data sets, and a dedicated prospective evaluation, we estimate that 132 
approximately two-thirds of MTB BSI is identified by one Myco/F Lytic blood culture (55% and 133 
73% in the data sets, and 64% in the prospective evaluation).  To our knowledge, this is the first 134 
investigation of the additional yield associated with number of TB blood cultures. One previous 135 
study randomised patients to 6 blood cultures at a single time point or 3 blood cultures at 2 136 
time points (but the same total number of cultures), and found no difference in recovery of M. 137 
tuberculosis between these arms.(8) This agrees with our prospective study finding that two 138 
blood culture at the same time point increases yield compared to a single culture.  139 
The importance of blood stream infection in HIV-associated tuberculosis disease is increasingly 140 
recognised. ‘Disseminated’ tuberculosis causes 2 out of 5 inpatient deaths amongst HIV 141 
infected inpatients in low-resource settings, and is undiagnosed prior to death in half of these 142 
cases.(17) This dissemination is assumed to occur via the blood stream, and, despite practical 143 
limitations, blood culture can be considered the gold-standard diagnostic test.(18) TB blood 144 
culture positivity is associated with significantly higher mortality than blood culture negative 145 
HIV-associated TB.(5-8)  In the context of a generalised HIV epidemic, M. tuberculosis is the 146 
most frequent blood culture isolate in hospitalised patients with severe sepsis.(2-5)  147 
With few exceptions,(7, 8) reports characterising MTB BSI have relied on a single blood culture 148 
for diagnosis; our results show this will have substantially under-estimated the true point 149 
prevalence. This has implications for studies of HIV-associated TB pathogenesis, and supports 150 
calls for increased clinical research focused on MTB BSI, including development of blood based 151 
rapid diagnostics.(6) Where resources currently allow, an additional TB blood culture will 152 
increase culture diagnosis in seriously unwell HIV-infected inpatients, particularly when sputum 153 
is unobtainable. 154 
Although several independent data sets have been used in this study, our findings are not 155 
generalisable outside of high HIV-TB burden settings. Most high HIV-TB burden settings do not 156 
have routine access to TB blood cultures. The findings are, however, useful to inform research 157 
studies carried out in those settings. In this study we were unable to assess the relative cost-158 
effectiveness of additional blood cultures compared to other diagnostics – like induced sputum 159 
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or urine Xpert® MTB/RIF Ultra, and the urine-lipoarabinomannan assay – which are potentially 160 
more accessible in low resource settings. The data presented in this report do, however, give an 161 
opportunity to improve the reference standard in diagnostic performance studies assessing 162 
these novel diagnostics in the most critically unwell HIV-associated TB patients.  163 
 164 
Conclusion 165 
We estimate that a single TB blood culture underestimates the point prevalence of MTB BSI by 166 
approximately one-third. Additional blood cultures – even within the same 24-hour period – 167 
increase diagnostic yield by a proportion similar to that seen for non-mycobacterial BSI. We 168 
recommend, where resources allow, at least 2 blood cultures are taken when MTB BSI is 169 
suspected in unwell HIV-infected adults, particularly when sputum is unobtainable. These can 170 
be collected at the same time-point, prior to anti-TB treatment, in patients starting urgent 171 
empirical therapy. 172 
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 187 
Table 1. Additional MTB BSI diagnoses made by second Myco/F Lytic culture in KHTB and JHTB 188 
cohort studies. 189 
Cohort 
Either culture 
positive 
BC1+/BC2+ BC1+/BC2- BC1-/BC2+ 
Proportion identified 
only by 2nd culture 
KDHTB 79 44 17 18 0.23 (95%CI 0.14 to 0.32) 
JHTB 20 7 4 9 0.45 (95%CI 0.23 to 0.67) 
Combined 99 51 21 27 0.27 (95%CI 0.18 to 0.36) 
Notes: 190 
BC1 = 1st Myco/F Lytic blood culture; BC2 = 2nd Myco/F Lytic blood culture 191 
(chronologically).  192 
+ = positive; - = negative 193 
95%CI = 95% confidence interval by binomial distribution 194 
  195 
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FIGURE LEGENDS 197 
Figure 1. Patient recruitment and blood culture availability in prospective study. 198 
Figure 2. Cumulative yield for identifying MTB BSI with up to 6 serial Myco/F Lytic blood 199 
cultures.  200 
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